
Share
-
Copy
In 1847, Mr. Philip Morris opened a shop on London’s Bond Street. Today, we are a leading international tobacco company and now we’ve made a dramatic decision.
We’re building our future on smoke-free products that are a much better
choice for adult smokers than continued smoking.
Through it all, we will rely on our strength in building great brands, in innovating and inventing, and in surpassing consumer expectations.
Our key milestones
1847
1881
1894
1908
1919
1950s
1954
1957
1972
1987
1995
2000
2001
2003
2005
2009
2011
2013
2014
2015
2016
2017
2018
2019
2020
2021
PMI acquires PT HM Sampoerna Tbk in Indonesia and Compania Colombiana de Tabaco SA (Coltabaco) in Colombia. Both are the largest cigarette manufacturers in their respective countries.
PMI announces an agreement with the China National Tobacco Company (CNTC) for the licensed production of Marlboro in China and the establishment of an international equity joint venture outside China.
PMI establishes a strategic framework with Altria Group, Inc. under which Altria makes available its e-cigarette products to PMI for commercialization outside the United States and PMI makes available two of its candidate reduced-risk products exclusively to Altria for commercialization in the United States.
PMI is recognized by CDP, a leading environmental nongovernmental organization, as one of only five global 500 consumer-staples companies to be a carbon-disclosure leader, in recognition of its actions to reduce its carbon footprint.
PMI announces the investment of up to EUR 500 million to build its first reduced-risk product factory in Italy.
PMI acquires Nicocigs, a leading U.K.-based e-vapor company whose main brand is Nicocig
PMI pilots IQOS, its first heat-not-burn platform in its reduced-risk products portfolio, in Italy and Japan.
PMI launches IQOS in key cities in Portugal, Romania, Russia, and Switzerland.
PMI launches an e-vapor product in Spain and Israel, based on its cross-licensing agreement with Altria Group, Inc.
PMI joins the United Nations Global Compact, affirming its commitment to the United Nations Sustainable Development Goals.
The launch of the PMI IMPACT initiative, investing USD 100 million to fund anti-illicit trade efforts globally over a period of three years.
PMI announces its vision to deliver a smoke-free future, and starts shifting its resources toward the development and responsible marketing of scientifically substantiated smoke-free products.
The number of adults who have stopped smoking and switched to IQOS reaches 1.5 million across 21 markets.
Following national and regional awards stretching back to 2014, PMI is recognized as a Global Top Employer.
PMI submits premarket tobacco product applications for IQOS to the U.S. FDA.
Marc Firestone, then-General Counsel for PMI, gives expert testimony at the U.S. Commission of Security and Cooperation on the global threats posed by illicit tobacco.
The number of adults who have stopped smoking and switched to IQOS reaches 4.7 million across 38 markets.
Launch of IQOS 3 and IQOS 3 MULTI.
PMI publishes a position paper supporting the WHO FCTC Protocol to Eliminate Illicit Trade in Tobacco Products.
The number of adults who have stopped smoking and switched to IQOS reaches 6.6 million across 44 markets.
PMI becomes the first multinational to obtain Global EQUAL-SALARY Certification.
Launch of IQOS 3 DUO.
The online hub for “unsmokers,” unsmokeyourworld.com, launches.
The FDA authorizes IQOS for sale in the U.S., confirming that it is appropriate for the protection of public health, following a comprehensive assessment of PMI’s premarket tobacco product applications (PMTAs) filed in 2017.
The number of adults who have had stopped smoking and switched to IQOS reaches 9.7 million across 52 markets.
PMI launches its first Integrated Report, providing a comprehensive overview of PMI’s progress toward transformation, as well as environmental, social, and governance (ESG) issues.
The FDA authorizes the marketing of IQOS 2.4 in the U.S. as a modified risk tobacco product with reduced exposure information.
The Board of PMI reaffirms the company’s commitment to its corporate purpose of delivering a smoke-free future.
The number of adults who have stopped smoking and switched to IQOS reaches 12.7 million across 64 markets.